Business Wire

AHS Properties: At 26, Abbas Sajwani Is Deploying Billions Into Dubai’s Future

21.5.2026 08:00:00 CEST | Business Wire | Press release

Share

Named the youngest billionaire in real estate globally by Forbes, the AHS Properties founder is scaling a AED 50 billion pipeline on a single conviction: Dubai is no longer a luxury market - it’s a capital destination.

While global real estate capital recalibrates, Abbas Sajwani is accelerating.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260519804834/en/

Abbas Sajwani, Founder and CEO of AHS Properties. (Photo: AETOSWire)

The 26-year-old Founder and CEO of AHS Properties - recently recognised by Forbes as the youngest Arab billionaire and the youngest billionaire globally in real estate, with a net worth of $1.9 billion - is building one of the fastest-scaling development platforms in Dubai.

Since launching in 2021, AHS Properties has expanded from ultra-luxury villa redevelopments into a multi-billion-dollar portfolio spanning waterfront residential, Grade-A commercial, and large-scale mixed-use developments across Dubai’s most strategic corridors.

Its commercial flagship, AHS Tower on Sheikh Zayed Road, sold out during construction, while its broader pipeline is projected to reach AED 50 billion by year-end.

This growth is underpinned by a strategy that runs counter to broader market caution.

“The real risk in this market isn’t volatility, it’s waiting,” Sajwani said. “By the time conviction feels obvious, the opportunity is already priced in.”

At a time when segments of global capital have moved to the sidelines amid geopolitical and macroeconomic uncertainty, AHS Properties has continued to deploy, advancing strategic land acquisitions and launching new developments aligned with long-term demand.

Sajwani’s thesis is structural, not cyclical.

He believes Dubai is undergoing a permanent repositioning, from a discretionary luxury destination to a core hub for global capital, driven by sustained inflows of ultra-high-net-worth individuals, founders, and family offices.

“This isn’t about short-term demand,” he said. “It’s about where capital is choosing to live.”

That perspective is informed by early experience in financial markets. Beginning equity trading at 14, Sajwani developed a disciplined, long-term approach to capital allocation, one now applied at scale across real estate.

As global investors reassess geographic exposure, AHS Properties is emerging as a high-conviction operator, building not around market sentiment, but ahead of it.

For further media information visit: https://ahsproperties.com/abbas-sajwani/

About AHS Properties, please visit: https://ahsproperties.com/

Source: AETOSWire

View source version on businesswire.com: https://www.businesswire.com/news/home/20260519804834/en/

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Onera Will Showcase Its Onera hPSG® Solution at the SLEEP 2026 Conference June 14-17, 2026 in Baltimore, MD, USA.11.6.2026 15:00:00 CEST | Press release

Onera hPSG®, an end-to-end home polysomnography solution from Onera Health, will be prominently featured at SLEEP 2026. The medtech company will showcase its innovative technology at booth #600, present clinical experience with their solution in 3 poster sessions, and host an educational symposium titled “Scaling PSG for the Next Decade: Expanding Utilization of High-Complexity Home Testing.” Onera Health, a leader in transforming sleep medicine, announces that its end-to-end home polysomnography solution, the Onera hPSG® solution, will be prominently featured in multiple scientific presentations at the forthcoming SLEEP 2026 conference. The medtech company will showcase this innovative solution at booth #600 during the largest annual sleep medicine conference, which brings together leading experts and innovators in the field. Furthermore, in anticipation of new CPT codes, Onera Health will host an educational symposium on Scaling PSG for the Next Decade: Expanding Utilization of High-

Xsolla to Meet With Mobile Game Developers and Publishers at Pocket Gamer Connects Barcelona 202611.6.2026 15:00:00 CEST | Press release

Company to Highlight Direct-to-Consumer Web Shop Solutions and Global Payments Infrastructure at Europe's Premier Mobile Gaming Conference Xsolla, a leading global video game commerce company, today announced its participation in Pocket Gamer Connects (PGC) Barcelona 2026, taking place June 15-16 at the Hyatt Regency Barcelona in Barcelona, Spain. Xsolla will be on the ground for meetings with mobile game developers, publishers, and strategic partners, bringing its direct-to-consumer commerce infrastructure to one of the most deal-focused events in the European games calendar. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260611487209/en/ Graphic: Xsolla Now in its second year, PGC Barcelona has quickly established itself as a destination conference for mobile game businesses, drawing more than 1,000 attendees from over 47 countries and facilitating thousands of structured business meetings through its dedicated matchmaking

IQM Quantum Computer Goes Live at Supercomputing Center CINECA in Italy, Boosting National Compute Infrastructure and Research11.6.2026 14:50:00 CEST | Press release

The system will enable advanced applications in optimization, simulation, and machine learning. IQM Radiance quantum computer, featuring a 54-qubit processing unit. The system is being integrated into Leonardo, one of the world's fastest supercomputers. This is the second IQM quantum computer to be operational in Italy. The Italian Research Centre on High Performance Computing, Big Data, and Quantum Computing (ICSC) today inaugurated the IQM Radiance 54 quantum computer at CINECA, one of Europe's leading supercomputing centers, enabling advanced applications in optimization, simulation, and machine learning. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260611898215/en/ The moment Italy's second IQM quantum computer went live at CINECA in Bologna. IQM has previously announced its ongoing business combination with Real Asset Acquisition Corp (Nasdaq: RAAQ), which will result in IQM becoming a public company in mid-2026. The

Wyss Geneva Steps Into Its Next Chapter11.6.2026 13:33:00 CEST | Press release

Dr. Tracy Laabs named Director; Prof. Dr. Erwin Böttinger honored for his transformative leadership The Wyss Center for Bio and Neuroengineering in Geneva is pleased to announce the appointment of Dr. Tracy Laabs as Director, effective July 1st 2026. Dr. Laabs succeeds Prof. Dr. Erwin Böttinger, who leaves behind a fundamentally transformed organization: one that no longer just pursues breakthrough science but systematically turns it into ventures that reach patients. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260611328520/en/ Dr. Tracy Laabs, incoming Director, Wyss Center Geneva Since joining the Wyss Center as Director in April 2023, Prof. Böttinger brought a bold vision: to evolve the Center from a portfolio of promising projects into a disciplined engine for venture creation. Under his leadership, the Center spun off six companies in two years (including ABILITY Neurotech SA and Clee Medical SA in 2025) while simult

BeOne Showcases Landmark Phase 3 Data in CLL Patients Aged 80+ at EHA 2026, Reinforcing BRUKINSA Benefit11.6.2026 13:24:00 CEST | Press release

Nearly two-thirds of patients aged 80+ treated with BRUKINSA remained progression-free at six years, despite advanced age and high-risk featuresNew European patient research reveals safety, disease severity, and effectiveness are the top drivers for first-line CLL treatment decisions – not time on therapy BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced the presentation of a large Phase 3 dataset in patients with chronic lymphocytic leukemia or small lymphocytic lymphoma (CLL/SLL) aged 80 and older, showing sustained benefit with BRUKINSA after nearly 6.5 years of follow-up, reinforcing its role as the foundational BTK inhibitor. BRUKINSA is the only BTK inhibitor to demonstrate superior efficacy vs. ibrutinib in a Phase 3 trial.1 These data, one of the largest datasets of older patients with treatment-naive CLL, will be presented at the 2026 European Hematology Association (EHA) Congress in Stockholm, Sweden. Amit Agarwal, M.D.,

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye